Squarepoint’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,189
| Closed | -$12.3K | – | 2692 |
|
|
2025
Q1 | $12.3K | Sell |
11,189
-626
| -5% | -$689 | ﹤0.01% | 2698 |
|
|
2024
Q4 | $20.3K | Buy |
+11,815
| New | +$20.3K | ﹤0.01% | 2710 |
|
|
2024
Q2 | – | Sell |
-113,232
| Closed | -$459K | – | 2439 |
|
|
2024
Q1 | $459K | Buy |
113,232
+60,403
| +114% | +$245K | ﹤0.01% | 1714 |
|
|
2023
Q4 | $203K | Buy |
+52,829
| New | +$203K | ﹤0.01% | 2130 |
|
|
2023
Q3 | – | Sell |
-10,445
| Closed | -$50.2K | – | 2413 |
|
|
2023
Q2 | $50.2K | Sell |
10,445
-8,898
| -46% | -$42.8K | ﹤0.01% | 2287 |
|
|
2023
Q1 | $78.5K | Buy |
+19,343
| New | +$78.5K | ﹤0.01% | 2068 |
|
|
2022
Q1 | – | Sell |
-18,818
| Closed | -$127K | – | 2168 |
|
|
2021
Q4 | $127K | Buy |
+18,818
| New | +$127K | ﹤0.01% | 2249 |
|